{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:59:12Z","timestamp":1790452752540,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.scib.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:53:58Z","timestamp":1785858838000},"page":"4694-4713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhalable HUCMSC-Lipo biomimetic formulation inhibits fibroblast activation in mouse and non-human primate pulmonary fibrosis models"],"prefix":"10.1016","volume":"71","author":[{"given":"Fangyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoguo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Zhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2026.08.013_b0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00957-2022","article-title":"Idiopathic pulmonary fibrosis: state of the art for 2023","volume":"61","author":"Podolanczuk","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.scib.2026.08.013_b0010","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2026.08.013_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066354","article-title":"Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis","volume":"377","author":"Liu","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.scib.2026.08.013_b0020","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2026.08.013_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.scib.2026.08.013_b0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.scib.2026.08.013_b0035","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.202010-3832OC","article-title":"Saracatinib, a selective src kinase inhibitor, blocks fibrotic responses in preclinical models of pulmonary fibrosis","volume":"206","author":"Ahangari","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2026.08.013_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2022.05.039","article-title":"Novel drug delivery systems and disease models for pulmonary fibrosis","volume":"348","author":"Li","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.scib.2026.08.013_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.scib.2026.08.013_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2213-2600(18)30339-4","article-title":"Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, inpulsis-on","volume":"7","author":"Crestani","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.scib.2026.08.013_b0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01326-2023","article-title":"Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts","volume":"63","author":"Mayr","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.scib.2026.08.013_b0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","article-title":"Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis","volume":"631","author":"Tsukui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.08.013_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj3087","article-title":"Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis","volume":"16","author":"Khan","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.scib.2026.08.013_b0070","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.cell.2024.03.010","article-title":"Tracing the origin of alveolar stem cells in lung repair and regeneration","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.scib.2026.08.013_b0075","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41590-024-01934-6","article-title":"Tracing the origins of lung fibrosis","volume":"25","author":"Buckley","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.scib.2026.08.013_b0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41551-021-00740-x","article-title":"Inhibition of aberrant tissue remodelling by mesenchymal stromal cells singly coated with soft gels presenting defined chemomechanical cues","volume":"6","author":"Wong","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.scib.2026.08.013_b0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41422-020-0354-1","article-title":"Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis","volume":"30","author":"Wu","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.scib.2026.08.013_b0090","article-title":"Exosome processing and characterization approaches for research and technology development","volume":"9","author":"Lai","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.scib.2026.08.013_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.scib.2026.08.013_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","article-title":"Clinical applications of stem cell-derived exosomes","volume":"9","author":"Tan","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0110","article-title":"In situ repair abilities of human umbilical cord-derived mesenchymal stem cells and autocrosslinked hyaluronic acid gel complex in rhesus monkeys with intrauterine adhesion","volume":"6","author":"Wang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2026.08.013_b0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41392-025-02262-3","article-title":"Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0125","article-title":"Lung-penetrating biomimetic extracellular vesicle spherical nucleic acids for pulmonary fibrosis therapy through ROS scavenging and anti-inflammatory effects","volume":"6","author":"Lou","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.scib.2026.08.013_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","article-title":"Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation","volume":"4","author":"Yang","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.scib.2026.08.013_b0135","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s12276-023-01017-w","article-title":"Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by mir-29c and mir-129 intercellular transfer","volume":"55","author":"Nataliya","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.scib.2026.08.013_b0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.scib.2026.08.013_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115143","article-title":"In situ cellular hitchhiking of nanoparticles for drug delivery","volume":"204","author":"Udofa","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.scib.2026.08.013_b0155","article-title":"Cell membrane-coated lipid nanoparticles for drug delivery","volume":"6","author":"Zewail","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.scib.2026.08.013_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115781","article-title":"Artificial intelligence and machine learning guided optimization in drug delivery","volume":"232","author":"Ros","year":"2026","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scib.2026.08.013_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11307-014-0784-6","article-title":"Measuring extracellular pH in a lung fibrosis model with acidocest MRI","volume":"17","author":"Jones","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases","volume":"207","author":"Yang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2026.08.013_b0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103856","article-title":"Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases\u2014a systematic review","volume":"24","author":"Bundgaard-Nielsen","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0190","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/biom13121718","article-title":"Fibroblast activation protein alpha (FAP\u03b1) in fibrosis: beyond a perspective marker for activated stromal cells?","volume":"13","author":"Basalova","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.scib.2026.08.013_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2675","article-title":"A thy-1-negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials","volume":"10","author":"Abebayehu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2026.08.013_b0200","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/s41467-020-18397-6","article-title":"Translational pharmacology of an inhaled small molecule \u03b1v\u03b26 integrin inhibitor for idiopathic pulmonary fibrosis","volume":"11","author":"John","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.08.013_b0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41580-024-00777-1","article-title":"The role and regulation of integrins in cell migration and invasion","volume":"26","author":"Chastney","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.tcb.2024.02.011","article-title":"Unlocking mechanosensitivity: integrins in neural adaptation","volume":"34","author":"Jaudon","year":"2024","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0215","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41592-023-02037-0","article-title":"Hydrogel-based molecular tension fluorescence microscopy for investigating receptor-mediated rigidity sensing","volume":"20","author":"Wang","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.scib.2026.08.013_b0220","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1038\/s41467-024-54174-5","article-title":"Mechanics-activated fibroblasts promote pulmonary group 2 innate lymphoid cell plasticity propelling silicosis progression","volume":"15","author":"He","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2026.08.013_b0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.scib.2026.08.013_b0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and clinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2026.08.013_b0245","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41586-024-08542-2","article-title":"Runx2 promotes fibrosis via an alveolar-to-pathological fibroblast transition","volume":"640","author":"Fang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.08.013_b0250","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ats\/ers\/jrs\/alat clinical practice guideline: Treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2026.08.013_b0255","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","article-title":"Nintedanib: a review in fibrotic interstitial lung diseases","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.scib.2026.08.013_b0260","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: From pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.scib.2026.08.013_b0265","article-title":"Vesicular antibodies: a bioactive multifunctional combination platform for targeted therapeutic delivery and cancer immunotherapy","volume":"31","author":"Liu","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2026.08.013_b0270","first-page":"7","article-title":"Genetically engineered liposome-like nanovesicles as active targeted transport platform","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2026.08.013_b0275","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.70034","article-title":"Multifunctional biomimetic nanotherapeutics for anti-oxidative and anti-inflammatory synergistic therapy of corneal neovascularization","volume":"6","author":"Cai","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.scib.2026.08.013_b0280","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","article-title":"Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products","volume":"12","author":"Mebarki","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0285","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13287-019-1450-3","article-title":"Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application","volume":"10","author":"Cabrera-P\u00e9rez","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cr.7290323","article-title":"Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation","volume":"15","author":"Li","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.scib.2026.08.013_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117537","article-title":"Unveiling the immunogenicity of allogeneic mesenchymal stromal cells: challenges and strategies for enhanced therapeutic efficacy","volume":"180","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.scib.2026.08.013_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.147496","article-title":"Functionalized hyaluronic acid biomaterials-encouraged cancer immunotherapy through CD44-mediated targeting and cell surface engineering: a review","volume":"328","author":"Jangid","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.scib.2026.08.013_b0305","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1073\/pnas.1423520112","article-title":"Mechanical force effect on the two-state equilibrium of the hyaluronan-binding domain of CD44 in cell rolling","volume":"112","author":"Suzuki","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2026.08.013_b0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2022.10.006","article-title":"Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes","volume":"352","author":"Japiassu","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.scib.2026.08.013_b0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1083\/jcb.201505007","article-title":"Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction","volume":"211","author":"Fiore","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.scib.2026.08.013_b0325","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/acs.molpharmaceut.3c01146","article-title":"Nebulization and in vitro upper airway deposition of liposomal carrier systems","volume":"21","author":"Mi\u0161\u00edk","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.scib.2026.08.013_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122404","article-title":"Inhaled pulmonary surfactant biomimetic liposomes for reversing idiopathic pulmonary fibrosis through synergistic therapeutic strategy","volume":"303","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.scib.2026.08.013_b0335","article-title":"Size-dependent stability and luminescence property in organic aggregates","volume":"6","author":"Yang","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.scib.2026.08.013_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114173","article-title":"Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?","volume":"183","author":"Forest","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0345","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s12274-020-3180-3","article-title":"Recent applications and strategies in nanotechnology for lung diseases","volume":"14","author":"Zhong","year":"2021","journal-title":"Nano Res"},{"key":"10.1016\/j.scib.2026.08.013_b0350","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17425247.2021.1829590","article-title":"Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects","volume":"18","author":"Wauthoz","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.scib.2026.08.013_b0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17425247.2018.1502267","article-title":"Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies","volume":"15","author":"Osman","year":"2018","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.scib.2026.08.013_b0360","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.70175","article-title":"Macrophage-derived extracellular vesicles disguised aiegen\/ido1 inhibitor nanoplatform reactivate \u201cimmune-hot\u201d for photothermal immunotherapy via multi-dimensionally reprograms tumor microenvironment","volume":"6","author":"Li","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.scib.2026.08.013_b0365","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41588-024-01819-2","article-title":"Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis","volume":"56","author":"Franz\u00e9n","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.scib.2026.08.013_b0370","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1172\/JCI60519","article-title":"Building and maintaining the epithelium of the lung","volume":"122","author":"Rackley","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2026.08.013_b0375","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-022-04587-3","article-title":"Cell transcriptomic atlas of the non-human primate macaca fascicularis","volume":"604","author":"Han","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.scib.2026.08.013_b0380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00018-025-05620-0","article-title":"Identification of early genes in the pathophysiology of fibrotic interstitial lung disease in a new model of pulmonary fibrosis","volume":"82","author":"Hennion","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.scib.2026.08.013_b0385","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01903-2025","article-title":"Tissue-based categorisation of fibrotic interstitial pneumonias: when early diagnosis can make the difference","volume":"67","author":"Poletti","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1016\/j.scib.2026.08.013_b0390","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0282-2024","article-title":"Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review","volume":"34","author":"Simons","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0395","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0062-2017","article-title":"Physiology of the lung in idiopathic pulmonary fibrosis","volume":"27","author":"Plantier","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.scib.2026.08.013_b0400","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.124.268376","article-title":"Targeting fibroblast activation protein for molecular imaging of fibrotic remodeling in pulmonary arterial hypertension","volume":"66","author":"Hou","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.scib.2026.08.013_b0405","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.7150\/thno.106367","article-title":"Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies","volume":"15","author":"Dias","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.scib.2026.08.013_b0410","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2967\/jnumed.117.193532","article-title":"Optimization of a collagen-targeted PET probe for molecular imaging of pulmonary fibrosis","volume":"58","author":"D\u00e9sog\u00e8re","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.scib.2026.08.013_b0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1164\/rccm.202007-2897ED","article-title":"Molecular imaging of pulmonary fibrosis: another step forward","volume":"203","author":"Montesi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2026.08.013_b0420","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149426","article-title":"Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma","volume":"7","author":"Marangoni","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2026.08.013_b0425","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1165\/rcmb.2006-0178OC","article-title":"Enhanced myofibroblastic differentiation and survival in thy-1(-) lung fibroblasts","volume":"36","author":"Sanders","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0430","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97597","article-title":"\u0391v\u03b23 integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis","volume":"3","author":"Fiore","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2026.08.013_b0435","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.1095087","article-title":"Elastic behavior of cross-linked and bundled actin networks","volume":"304","author":"Gardel","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.scib.2026.08.013_b0440","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131152","article-title":"Soluble thy-1 reverses lung fibrosis via its integrin-binding motif","volume":"4","author":"Tan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2026.08.013_b0445","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41556-025-01697-8","article-title":"Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer","volume":"27","author":"Al-Hilal","year":"2025","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.scib.2026.08.013_b0450","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/s13287-025-04708-5","article-title":"Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments","volume":"16","author":"Hwang","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0455","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41392-025-02485-4","article-title":"Pig-to-human lung xenotransplantation: advancing xenogeneic respiratory transplantation and clinical translation","volume":"10","author":"Kwon","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2026.08.013_b0460","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12951-025-03769-1","article-title":"Lipid metabolism and lipid signaling in extracellular vesicles ontogeny: from biogenesis to functional execution","volume":"23","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnology"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326008790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326008790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:30:14Z","timestamp":1790451014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927326008790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":92,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2095927326008790"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.013","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable HUCMSC-Lipo biomimetic formulation inhibits fibroblast activation in mouse and non-human primate pulmonary fibrosis models","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Science China Press. Published by Elsevier B.V. and Science China Press. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}